Eva Hellström‐Lindberg

Research interests

Publications

• Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

  NEJM Evidence · 2022 · https://doi.org/10.1056/evidoa2200008

• International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

  Blood · 2022 · https://doi.org/10.1182/blood.2022015850

• Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

  Blood · 2022 · https://doi.org/10.1182/blood.2022015853

• TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

  Leukemia · 2019 · https://doi.org/10.1038/s41375-018-0351-2

• Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

  Blood · 2018 · 10.1182/blood-2018-06-857102

• Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells

  Cell · 2018 · 10.1016/j.cell.2018.03.008

• Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells

  Cell · 2018 · 10.1016/j.cell.2018.03.008

• Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

  Blood · 2018 · 10.1182/blood-2018-06-857102

• Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data

  Scientific Reports · 2017 · 10.1038/srep43169

• Evaluating Variant Calling Tools for Non-Matched Next-Generation Sequencing Data

  Scientific Reports · 2017 · 10.1038/srep43169

• Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

  Cancer Cell · 2014 · 10.1016/j.ccr.2014.03.036

• Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

  Cancer Cell · 2014 · 10.1016/j.ccr.2014.03.036

• Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

  Blood · 2013 · https://doi.org/10.1182/blood-2013-03-492884

• Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

  Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.46.8652

• Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

  Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.46.8652

• TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

  Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.31.8576

• A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

  Blood · 2011 · https://doi.org/10.1182/blood-2011-01-330126

• TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

  Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.31.8576

• Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission

  New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0912228

• Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

  Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.23.8329

• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

  Blood · 2009 · 10.1182/blood-2009-03-209262

• Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2009.24.7999

• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

  Blood · 2009 · 10.1182/blood-2009-03-209262

• Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia

  Journal of Clinical Oncology · 2009 · 10.1200/jco.2009.24.7999

• Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

  The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70003-8

• Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

  Haematologica · 2008 · 10.3324/haematol.13405

• Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

  Haematologica · 2008 · 10.3324/haematol.13405

• A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

  British Journal of Haematology · 2003 · 10.1046/j.1365-2141.2003.04153.x

• A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

  British Journal of Haematology · 2003 · 10.1046/j.1365-2141.2003.04153.x

• Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level

  Blood · 2000 · 10.1182/blood.v96.6.2012

• Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level

  Blood · 2000 · 10.1182/blood.v96.6.2012

• Efficacy of erythropoietin in the myelodysplastic syndromes: a meta‐analysis of 205 patients from 17 studies

  British Journal of Haematology · 1995 · 10.1111/j.1365-2141.1995.tb08909.x

• Efficacy of erythropoietin in the myelodysplastic syndromes: a meta‐analysis of 205 patients from 17 studies

  British Journal of Haematology · 1995 · 10.1111/j.1365-2141.1995.tb08909.x

Current projects

No projects listed.